English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

We present the case of a neuroleptic malignant syndrome (NMS) with lethal outcome in a patient with probable Alzheimer's disease (AD) treated with quetiapine in combination with pipamperone and mirtazapine. Although neuroleptic sensitivity in AD patients is low, we should remain aware of this risk. The NMS management of old people with advanced dementia may frequently be limited by multimorbidity, hence even early recognition and therapy may not prevent the lethal outcome.

Ein Quetiapin-assoziiertes malignes Neuroleptika-Syndrom mit letalem Ausgang bei einem Patienten mit wahrscheinlicher Alzheimer Demenz